Literature DB >> 31960496

Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in adult cohort: a real-life Italian tertiary centre experience.

S Ribero1, M T Giura1, R Viola2, A Ramondetta1, N Siliquini1, P Cardone1, L Tonella1, P Quaglino1, P Dapavo1, M Panzone1, M Ortoncelli1, M T Fierro1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31960496     DOI： 10.1111/jdv.16219

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  8 in total

1.  Dupilumab induces a rapid decrease of pruritus in adolescents: A pilot real-life study.

Authors:  Luca Mastorino; Riccardo Viola; Michele Panzone; Gianluca Avallone; Giuseppe Gallo; Michela Ortoncelli; Giovanni Cavaliere; Pietro Quaglino; Simone Ribero
Journal:  Dermatol Ther       Date:  2021-09-02       Impact factor: 3.858

2.  Impact on health-related quality of life and symptoms of anxiety and depression after 32 weeks of Dupilumab treatment for moderate-to-severe atopic dermatitis.

Authors:  Marco Miniotti; Giulia Lazzarin; Michela Ortoncelli; Luca Mastorino; Simone Ribero; Paolo Leombruni
Journal:  Dermatol Ther       Date:  2022-03-03       Impact factor: 3.858

Review 3.  Conjunctivitis in patients with atopic dermatitis treated with dupilumab.

Authors:  Sandra Ferreira; Tiago Torres
Journal:  Drugs Context       Date:  2020-05-04

Review 4.  A Literature Review of Real-World Effectiveness and Safety of Dupilumab for Atopic Dermatitis.

Authors:  Masahiro Kamata; Yayoi Tada
Journal:  JID Innov       Date:  2021-07-30

Review 5.  Topical and Conventional Systemic Treatments in Atopic Dermatitis: Have They Gone Out of Fashion?

Authors:  Giulia Calabrese; Gaetano Licata; Alessio Gambardella; Alina De Rosa; Roberto Alfano; Giuseppe Argenziano
Journal:  Dermatol Pract Concept       Date:  2022-01-01

6.  Chronic Pruritus in Atopic Patients Treated with Dupilumab: Real Life Response and Related Parameters in 354 Patients.

Authors:  Luca Mastorino; François Rosset; Federica Gelato; Michela Ortoncelli; Giovanni Cavaliere; Pietro Quaglino; Simone Ribero
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-17

7.  Real-world experience of dupilumab in the treatment of moderate-to-severe atopic dermatitis.

Authors:  Nicole S Kim; Khalad Maliyar; Luciana Oliveira; Ashley O'Toole; Melinda J Gooderham
Journal:  Int J Dermatol       Date:  2020-08-09       Impact factor: 2.736

8.  Epidemiology and management of atopic dermatitis in England: an observational cohort study protocol.

Authors:  Simon de Lusignan; Helen Alexander; Conor Broderick; John Dennis; Andrew McGovern; Claire Feeney; Carsten Flohr
Journal:  BMJ Open       Date:  2020-09-16       Impact factor: 2.692
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.